Eversept Partners as of Dec. 31, 2017
Portfolio Holdings for Eversept Partners
Eversept Partners holds 47 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Array BioPharma | 10.3 | $16M | 1.2M | 12.80 | |
| Aerie Pharmaceuticals | 9.4 | $14M | 242k | 59.75 | |
| Zogenix | 5.7 | $8.7M | 218k | 40.05 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 5.7 | $8.7M | 58k | 149.86 | |
| Sanofi-Aventis SA (SNY) | 5.2 | $8.1M | 188k | 43.00 | |
| Ensign (ENSG) | 4.8 | $7.4M | 332k | 22.24 | |
| R1 Rcm | 4.7 | $7.2M | 1.6M | 4.41 | |
| Tesaro | 4.6 | $7.1M | 86k | 82.87 | |
| Radius Health | 4.0 | $6.2M | 195k | 31.77 | |
| Teligent | 3.9 | $6.0M | 1.7M | 3.63 | |
| eHealth (EHTH) | 3.7 | $5.7M | 329k | 17.37 | |
| Puma Biotechnology (PBYI) | 3.5 | $5.4M | 55k | 98.85 | |
| Nevro (NVRO) | 2.9 | $4.5M | 65k | 69.04 | |
| Spdr S&p 500 Etf Tr option | 2.7 | $4.1M | 900.00 | 4588.89 | |
| BioMarin Pharmaceutical (BMRN) | 2.6 | $4.1M | 46k | 89.17 | |
| Alexion Pharmaceuticals | 2.6 | $4.0M | 34k | 119.58 | |
| Quality Care Properties | 2.2 | $3.4M | 249k | 13.81 | |
| Avexis | 2.0 | $3.0M | 27k | 110.67 | |
| Envision Healthcare | 1.8 | $2.7M | 80k | 34.56 | |
| Ablynx Nv | 1.6 | $2.5M | 101k | 24.99 | |
| Caretrust Reit (CTRE) | 1.5 | $2.3M | 138k | 16.95 | |
| Myokardia | 1.4 | $2.1M | 50k | 42.10 | |
| Argenx Se (ARGX) | 1.1 | $1.7M | 28k | 63.12 | |
| Zimmer Holdings (ZBH) | 1.1 | $1.7M | 14k | 120.86 | |
| Invacare Corporation | 1.1 | $1.6M | 97k | 16.85 | |
| Axogen (AXGN) | 1.1 | $1.6M | 58k | 28.31 | |
| Abiomed | 1.1 | $1.6M | 8.6k | 187.46 | |
| Global Blood Therapeutics In | 1.0 | $1.5M | 39k | 39.36 | |
| Pacira Pharmaceuticals (PCRX) | 0.7 | $1.1M | 25k | 45.66 | |
| Clovis Oncology | 0.7 | $1.1M | 16k | 68.00 | |
| BioCryst Pharmaceuticals (BCRX) | 0.6 | $974k | 198k | 4.91 | |
| Magellan Health Services | 0.6 | $896k | 9.3k | 96.53 | |
| Align Technology (ALGN) | 0.6 | $889k | 4.0k | 222.25 | |
| Varex Imaging (VREX) | 0.5 | $832k | 21k | 40.19 | |
| Iradimed (IRMD) | 0.5 | $774k | 51k | 15.16 | |
| Arbutus Biopharma (ABUS) | 0.3 | $543k | 108k | 5.05 | |
| Ascendis Pharma A S (ASND) | 0.3 | $485k | 12k | 40.02 | |
| Ophthotech | 0.3 | $465k | 149k | 3.12 | |
| Civitas Solutions | 0.3 | $402k | 24k | 17.09 | |
| Aradigm | 0.2 | $349k | 52k | 6.70 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.2 | $340k | 50k | 6.80 | |
| Seaspine Holdings | 0.2 | $313k | 31k | 10.13 | |
| Invuity | 0.2 | $279k | 45k | 6.20 | |
| Sierra Oncology | 0.2 | $250k | 67k | 3.73 | |
| Aquinox Pharmaceuticals | 0.1 | $235k | 20k | 11.75 | |
| Quotient | 0.0 | $52k | 11k | 4.95 | |
| Celgene Corp right 12/31/2011 | 0.0 | $6.0k | 6.0k | 1.00 |
